OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
Yuxiang Zhao, Linchuan Gan, Dangjin Ke, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Yuxiang Zhao, Linchuan Gan, Dangjin Ke, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Showing 13 citing articles:
Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies
Rohit Singh, Pankaj Chandley, Soma Rohatgi
ImmunoHorizons (2023) Vol. 7, Iss. 12, pp. 886-897
Open Access | Times Cited: 28
Rohit Singh, Pankaj Chandley, Soma Rohatgi
ImmunoHorizons (2023) Vol. 7, Iss. 12, pp. 886-897
Open Access | Times Cited: 28
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation
Oana Hangiu, Rocío Navarro, Susana Frago, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Oana Hangiu, Rocío Navarro, Susana Frago, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Anti-Drug Antibody Response to Therapeutic Antibodies and Potential Mitigation Strategies
Erin L. Howard, Melanie M. Goens, Leonardo Susta, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 299-299
Open Access
Erin L. Howard, Melanie M. Goens, Leonardo Susta, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 299-299
Open Access
In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
Yuta Suzuki, Takayuki Miyazaki, Yoko Ida, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102467-102467
Open Access
Yuta Suzuki, Takayuki Miyazaki, Yoko Ida, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102467-102467
Open Access
Key Considerations for a Prostate Cancer mRNA Vaccine
Guofu Lin, Ahmed Elkashif, Chayanika Saha, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104643-104643
Open Access
Guofu Lin, Ahmed Elkashif, Chayanika Saha, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104643-104643
Open Access
Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses
Hang Chi, Suo-Qun Zhao, Ru-Yi Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Hang Chi, Suo-Qun Zhao, Ru-Yi Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Steering the course of CAR T cell therapy with lipid nanoparticles
Muhammad Babar Khawar, Ali Afzal, Yue Si, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Muhammad Babar Khawar, Ali Afzal, Yue Si, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Structure‐based design of antibodies targeting the EBNA1 DNA‐binding domain to block Epstein–Barr virus latent infection and tumor growth
Yongyue Han, Fang Wu, Ying Zhang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 1
Yongyue Han, Fang Wu, Ying Zhang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 1
Homologies between Chloroplast, plasma membrane, plastid, chloroplast envelope, putative [Theobroma cacao] and PEG10 protein [Homo sapiens]: a starting point for to deliver drugs to cells?
Luís Jesuino de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Luísa Correia Matos de Oliveira, et al.
Research Square (Research Square) (2024)
Open Access
Luís Jesuino de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Luísa Correia Matos de Oliveira, et al.
Research Square (Research Square) (2024)
Open Access
In vivo expression of an mRNA encoded multi-mechanistic mAb combination against Staphylococcus aureus and protection in disease model
Christine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2505-2518
Open Access
Christine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2505-2518
Open Access
Better, Faster, Stronger: Accelerating mRNA ‐Based Immunotherapies With Nanocarriers
Henrique Carvalho, Tiago A. S. Fidalgo, Rita C. Acúrcio, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Open Access
Henrique Carvalho, Tiago A. S. Fidalgo, Rita C. Acúrcio, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Open Access
Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo
Yuhang Zhang, Chongyu Tian, Xinyang Yu, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1315-1315
Open Access
Yuhang Zhang, Chongyu Tian, Xinyang Yu, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1315-1315
Open Access
